| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Canada | 3 | |
| #3 | Brazil | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Republic of Korea | 2 | |
| #6 | Singapore | 2 | |
| #7 | Australia | 1 | |
| #8 | Taiwan | 1 | |
| #9 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Macromolecular chemistry and polymers |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Special macromolecular compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wang Chang Yi | 15 |
| #2 | Verma Ajay | 2 |
| #3 | Chang Yi Wang | 2 |
| #4 | Wang Chang-Yi | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020142522A2 | Peptide immunogens targeting calcitonin gene-related peptide (cgrp) and formulations thereof for prevention and treatment of migraine | |
| CA3114657A1 | Peptide immunogen constructs directed against dipeptide repeat proteins from c9orf72 | |
| US2021101948A1 | Tau peptide immunogen constructs | |
| CA3067231A1 | Peptide immunogens from the c-terminal end of alpha-synuclein protein and formulations thereof for treatment of synucleinopathies | |
| TWI676635B | Peptide immunogens from the C-terminal end of alpha-synuclein protein and formulations thereof for treatment of synucleinopathies |